共 50 条
- [21] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins [J]. Clinical Pharmacokinetics, 2010, 49 : 567 - 571
- [23] Comparison of apixaban and rivaroxaban trough anti-Xa activity. [J]. PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239